An Oregon Health Sciences University study reported statins such as Lipitor and Pravachol may cut the risk of aggressive forms of prostate cancer by as much as 62%, according to a study in the American Journal of Epidemiology. Statins previously have been linked to reduced risk of other malignancies, but this study's researchers looked specifically at prostate cancer, though they said a larger study would be needed to confirm their results.

Full Story:
Taiwan News

Related Summaries